Robbins LLP Asks Fractyl Health Stockholders to Contact Firm for Class Action Information
Law firm Robbins LLP is urging Fractyl Health stockholders who lost money investing in the company to contact the firm regarding information about leading a class action lawsuit.
San Diego, CA – September 10, 2026 – Shareholder rights law firm Robbins LLP is informing investors that a class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ: GUTS) securities between January 13, 2025, and a specified later date.
The lawsuit alleges that Fractyl Health and its executives made materially false or misleading statements and/or failed to disclose material adverse information about the company’s business and prospects. Investors who purchased Fractyl Health stock during the specified period and suffered losses may be eligible for compensation.
Robbins LLP is investigating these claims and encourages all affected investors to contact the firm to learn more. The goal is to determine if there are grounds for a class action and to represent the interests of the shareholders. Further details can be obtained by contacting Robbins LLP.
Robbins LLP specializes in shareholder rights litigation and has a history of successfully representing investors in similar cases. Their expertise can assist Fractyl Health stockholders in understanding their legal options and potentially recovering damages for their losses.